• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: Edaravone and (+)-Borneol
Date Designated: 08/11/2020
Orphan Designation: Treatment of Amyotrophic Lateral Sclerosis.
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Yantai Yenepharma. Co., Ltd
Inner No. 2, No.32 Zhujiang Road
Yantai Economic and Technological Development Zone
Yantai, Shandong Province 264006

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.